Oppenheimer & Co’s Capital Group Dividend Value ETF CGDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.3M Buy
290,115
+12,050
+4% +$567K 0.15% 129
2026
Q1
$11.8M Buy
278,065
+75,492
+37% +$3.35M 0.14% 149
2025
Q4
$8.84M Buy
202,573
+13,437
+7% +$577K 0.13% 176
2025
Q3
$7.95M Buy
189,136
+6,154
+3% +$253K 0.1% 217
2025
Q2
$7.23M Buy
182,982
+88,753
+94% +$3.22M 0.1% 223
2025
Q1
$3.36M Buy
94,229
+13,160
+16% +$478K 0.05% 395
2024
Q4
$2.86M Buy
81,069
+3,438
+4% +$125K 0.04% 447
2024
Q3
$2.83M Buy
77,631
+5,226
+7% +$182K 0.04% 436
2024
Q2
$2.39M Buy
72,405
+9,511
+15% +$310K 0.04% 470
2024
Q1
$2.04M Buy
62,894
+4,905
+8% +$151K 0.03% 506
2023
Q4
$1.73M Buy
57,989
+1,626
+3% +$44.8K 0.03% 538
2023
Q3
$1.49M Buy
56,363
+137
+0.2% +$3.75K 0.03% 547
2023
Q2
$1.52M Buy
56,226
+8,151
+17% +$209K 0.03% 548
2023
Q1
$1.2M Buy
48,075
+17,228
+56% +$422K 0.03% 624
2022
Q4
$728K Buy
+30,847
New +$707K 0.02% 791

Other funds holding CGDV

Oppenheimer & Co's CGDV Position: Q2 2026 in Review

Oppenheimer & Co increased its Capital Group Dividend Value ETF (CGDV) stake by 4.3% in Q2 2026, buying an estimated $567K and bringing the position to 290,115 shares worth $14.3M. The position accounts for 0.15% of the portfolio, ranked #129.

Oppenheimer & Co first reported a position in CGDV in Q4 2022 and has held it in 15 quarters since. 777 funds tracked by Wall St. Rank hold CGDV as of Q2 2026.

  • Oppenheimer & Co held 290,115 shares of Capital Group Dividend Value ETF worth $14.3M as of Q2 2026.
  • Oppenheimer & Co bought 12,050 Capital Group Dividend Value ETF shares in Q2 2026, an estimated $567K.
  • Capital Group Dividend Value ETF made up 0.15% of Oppenheimer & Co's portfolio in Q2 2026, its #129 holding.
  • Oppenheimer & Co first reported a position in Capital Group Dividend Value ETF in Q4 2022 and has held it in 15 quarters since.
  • 777 funds tracked by Wall St. Rank held Capital Group Dividend Value ETF as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.